Inventor profile of:

Jason YANTHA

City:

Brampton

Country:

Canada

Published Applications:

12

Last publication date:

2016-05-12

Top Assignees for applications by Jason YANTHA

The entities that hold a legal rights for patent applications filed by inventor YANTHA Jason:

Recent patent applications by YANTHA Jason

Jason YANTHA from Brampton, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-05-12
US20160128967A1
Human necessities

PROCESS AND COMPOSITION FOR STABILIZATION OF VULNERABLE PLAQUE UTILIZING A COMBINATION OF A STATIN AND OMEGA 3 FATTY ACIDS

#2 | 2015-10-01
US20150272920A1
Human necessities

METHOD FOR TREATING OBESITY WITH ANTI-OBESITY FORMULATIONS AND OMEGA 3 FATTY ACIDS FOR THE REDUCTION OF BODY WEIGHT IN CARDIOVASCULAR DISEASE PATIENTS (CVD) AND DIABETICS

#3 | 2015-09-03
US20150246012A1
Human necessities

OMEGA 3 FATTY ACID FOR USE AS A PRESCRIPTION MEDICAL FOOD AND OMEGA 3 FATTY ACID DIAGNOSTIC ASSAY FOR THE DIETARY MANAGEMENT OF CARDIOVASCULAR PATIENTS WITH CARDIOVASCULAR DISEASE (CVD) WHO ARE DEFICIENT IN BLOOD EPA AND DHA LEVELS

#4 | 2015-08-13
US20150224075A1
Human necessities

OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH

#5 | 2015-07-16
US20150196571A1
Human necessities

Process and composition for stabilization of vulnerable plaque utilizing a combination of a statin and omega 3 fatty acids

#6 | 2015-04-30
US20150119414A1
Human necessities

STATIN AND OMEGA 3 FATTY ACIDS FOR REDUCTION OF APOLIPOPROTEIN-B LEVELS

#7 | 2015-04-30
US20150119368A1
Human necessities

CHOLESTEROL ABSORPTION INHIBITOR AND OMEGA 3 FATTY ACIDS FOR THE REDUCTION OF CHOLESTEROL AND FOR THE PREVENTION OR REDUCTION OF CARDIOVASCULAR, CARDIAC AND VASCULAR EVENTS

#8 | 2013-03-28
US20130079310A1
Human necessities

Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels

#9 | 2013-02-14
US20130040927A1
Human necessities

Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events

#10 | 2013-02-14
US20130040913A1
Human necessities

Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels

#11 | 2013-02-07
US20130034535A1
Human necessities

Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics

#12 | 2012-11-29
US20120302639A1
Human necessities

OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH

InventorID:

77994 ⎘